Journal · Updated 2026-08-11
Sprout Health Review 2026: Homepage Prices, Funnel Rates, and the Brand Sticker Shock
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
Short answer — August 2026
Per homepage captures from July 2026, Sprout Health advertises compounded semaglutide "starting at" one forty-nine and tirzepatide at one ninety-nine — entry-dose figures whose final rate is personalized inside the signup funnel, the definition of the funnel-gated structure methodology §4 records without ranking. The same third-party audit captured Sprout's brand-name options at figures near seventeen ninety-nine for Wegovy and nineteen ninety-nine for Zepbound — multiples of the manufacturers' own three forty-nine and four forty-nine direct channels, a spread that says more about the program's pricing posture than any compounded headline does. The review is therefore two sentences: the compounded numbers await your funnel confirmation, and the brand numbers should send every brand buyer straight to LillyDirect and NovoCare instead.
What the funnel must answer, and verdict
Three items in writing before payment: the ongoing maintenance-dose rate (the personalized number, at your dose — the only figure that can be compared to bmiMD's one twenty-nine or the one sixty-nine-to-one seventy-nine tirzepatide tier); what "personalized" varies on (dose alone, or state, plan, and promo); and the pharmacy name for the standard verification. If the funnel returns competitive maintenance figures, Sprout joins the rankable field at whatever they are; our capture file has a row waiting. Until then the verdict is structural: recorded, labeled entry-priced, and — on the brand side specifically — outpriced by the manufacturers by margins that make comparison shopping not just advisable but arithmetic. The one universal takeaway Sprout usefully illustrates: in 2026, no brand GLP-1 should ever be bought through a reseller without first pricing the maker's own channel, because the gap can be a factor of four.
Questions people ask
What does Sprout Health cost?
Advertised homepage entry prices (July 2026): compounded semaglutide 'starting at' $149, tirzepatide $199 — with the final rate personalized in the signup funnel, so your maintenance-dose figure must come from enrollment in writing. Funnel-gated rows are recorded, not ranked, in our tables.
Why are Sprout's brand prices so high?
Third-party captures listed its brand options near $1,799 (Wegovy) and $1,999 (Zepbound) — roughly four to five times the manufacturers' direct channels ($349 pen, $299–$449 vials). Whatever the reason, the practical rule it proves: always price LillyDirect/NovoCare before buying brand GLP-1s through any reseller.
Is Sprout's $149 semaglutide real?
It's a real advertised entry-dose figure — and not your price until the funnel personalizes it. Get the ongoing maintenance rate, what it varies on, and the pharmacy name in writing; then compare that number (not the homepage one) against the $129 published-maintenance floor.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.